| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 157.887 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 212.785 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 205.159 | 84 |
| GSM780719 | Untreated after 4 days (C1_2) | 188.373 | 83 |
| GSM780720 | Untreated after 4 days (C2_2) | 144.389 | 80 |
| GSM780721 | Untreated after 4 days (C3_2) | 155.772 | 81 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 175.459 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 201.997 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 215.562 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 230.882 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 168.935 | 82 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 185.596 | 83 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 194.307 | 83 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 186.646 | 83 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 163.331 | 81 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 187.753 | 83 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 193.241 | 83 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 198.798 | 83 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 160.644 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 262.475 | 86 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 213.932 | 84 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 212.221 | 84 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 210.904 | 84 |